Latest News On Investigation

Latest California Healthline Stories

KHN-NPR’s ‘Bill of the Month’ at 5: A Treasury of Solutions for Confounding Medical Bills

Readers and listeners shared more than 1,000 personal stories of medical billing problems with KHN-NPR’s “Bill of the Month” investigative series this year, helping us illuminate the financial decisions patients are pressed to make in their most vulnerable moments.

ER Doctors Call Private Equity Staffing Practices Illegal and Seek to Ban Them

Doctors, consumer advocates, and some lawmakers are looking forward to a California lawsuit against private equity-backed Envision Healthcare. The case is part of a multistate effort to enforce rules banning corporate ownership of physician practices.

How Medicare Advantage Plans Dodged Auditors, Overcharged Taxpayers by Millions

Facing rare scrutiny from federal auditors, some Medicare Advantage health plans failed to produce any records to justify their payments, government records show. The audits revealed millions of dollars in overcharges to Medicare over three years.

KHN Investigation: The System Feds Rely On to Stop Repeat Health Fraud Is Broken

A months-long KHN examination of the system meant to bar fraudsters from Medicaid, Medicare, and other federal health programs found gaping holes and expansive gray areas through which banned individuals slip to repeatedly bilk taxpayer-funded programs.

Empresas de capital riesgo invierten en el negocio de los ensayos clínicos de medicamentos. ¿Cuál es el riesgo para los pacientes?

Para lanzar un nuevo fármaco al mercado, la Administración de Alimentos y Medicamentos (FDA) exige a las farmacéuticas estudios exhaustivos para demostrar su seguridad y eficacia. Conseguir que un medicamento salga al mercado unos meses antes, y con menos gastos de lo habitual, puede traducirse en beneficios millonarios para el fabricante.